Answers are grounded in this paper and cite their sources.
Tumor necrosis factor α (TNF-α) inhibitor–induced lupuslike syndrome (TAILS) is a newly described entity that refers to the onset of subacute cutaneous lupus erythematosus (SCLE) during drug therapy with TNF-α antagonists.
No takes yet. Share an insight, caveat, or question.
David Crasto (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: